Medicaid Block Grants: Allowing More State Flexibility To Limit Rx Coverage?

Medicaid block grant funding mechanism, which could allow states to bypass coverage requirements in the Medicaid drug rebate program, surfaces in House American Health Care Act.

The latest version of the American Health Care Act would allow states the option of choosing to get their federal Medicaid contribution in the form of a block grant and might also permit them to reduce the number of prescription drugs their Medicaid programs cover.

The coverage flexibility could allow for an exemption from the Medicaid drug rebate program, which requires Medicaid to cover drugs...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicaid

PS-MarketAccess (Premium-2): Why Financial Scammers Are So Successful Targeting Doctors

 
• By 

Doctors are increasingly falling victim to financial scams due to their high incomes, busy schedules, and trust in professional networks. Recognizing the tactics scammers use and the reasons behind physicians’ susceptibility is essential for protecting medical professionals.

PBMs and Vertical Integration: CBO Adds To Growing Concerns About Negative Impacts

 

Congressional Budget Office responses to questions from US lawmakers on pharmacy benefit managers could add to the momentum for PBM reforms to go further than the current leading proposals.

Vertex Opens New Front In Patient Assistance Conflict Between Pharma, HHS Inspector General

 
• By 

Vertex’s fertility preservation assistance program would provide up to $70,000 in financial support for in vitro fertilization and other services to patients prescribed Casgevy.

CMS Proposal To Further Reduce Medicaid 'Best Prices' Thwarted, For Now

 
• By 

The agency says it will collect additional information from manufacturers on methods for adding up price concessions from the supply chain before moving ahead.

More from Government Payers

PBMs and Vertical Integration: CBO Adds To Growing Concerns About Negative Impacts

 

Congressional Budget Office responses to questions from US lawmakers on pharmacy benefit managers could add to the momentum for PBM reforms to go further than the current leading proposals.

Pink Sheet Podcast: What We Learned From The First Batch Of Medicare Negotiated Drug Prices

 

Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.

A Better Deal: Medicare Discounts Surpass Estimated PBM-Negotiated Rebates

 
• By 

But the amount of savings realized when the Medicare negotiated prices go into effect in 2026 remains the subject of debate.